Once again, with the majority of brokers across Australia taking a well-earned break, broker notes will be few and far between until next week.
In light of this, listed below are a few recent broker recommendations that remain very relevant today. Here are three ASX shares rated as buys:
Appen Ltd (ASX: APX)
According to a note out of Citi, its analysts have a buy rating and $17.10 price target on this artificial intelligence data services company's shares. Although Citi notes that Amazon's entry into the fully managed data labelling service market could increase competition in the Enterprise space, it doesn't expect it to impact Appen's relationships with major tech companies. The broker also highlights that Amazon's move is a sign that Appen's services remain in demand with end users despite concerns about self-learning systems. The Appen share price is currently trading at $10.13.
CSL Limited (ASX: CSL)
A note out of Morgans reveals that its analysts have an add rating and $334.70 price target on this biotherapeutics giant's shares. The broker was pleased with the acquisition of Vifor Pharma for $17 billion and believes it will complement its existing business and provide growth opportunities. Morgans also doesn't believe the acquisition is being undertaken because CSL's core plasma business' growth is over. The CSL share price is fetching $283.60 on Thursday.
De Grey Mining Limited (ASX: DEG)
Analysts at Macquarie have put an outperform rating and $1.70 price target on this gold developer's shares. Macquarie is a fan of De Grey Mining partly due to its Mallina gold project. The broker believes this project has tier-1 potential and could support upwards of 15 years of production. Macquarie expects production to commence in FY 2026 and generate significant free cash flow each year. The De Grey share price is trading at $1.14 today.
